Literature DB >> 16703776

Haptens as drugs: contact allergens are powerful topical immunomodulators.

Aton M Holzer1, Leonard L Kaplan, William R Levis.   

Abstract

For the past 40 years, dermatologists have safely used contact sensitizers such as dinitrochlorobenzene (DNCB), diphenylcyclopropenone (DPCP), and squaric acid dibutylester (SADBE) for the treatment of warts, alopecia areata, and even skin cancers. Most of these studies have utilized these powerful topical immunomodulators in acetone, a volatile solvent that precludes development of contact sensitizers as products. We have overcome these problems and stabilized these topical immunomodulators in a non-volatile, nonirritating GRAS (generally regarded as safe) vehicle. The current review article covers the traditional use of contact sensitizers for a variety of benign and malignant conditions and discusses possible mechanisms in relation to developments in modem molecular immunodermatology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703776

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  7 in total

1.  Topical diphencyprone as an effective treatment for cutaneous metastatic melanoma.

Authors:  Young Jin Kim
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

2.  TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.

Authors:  Frank Martiniuk; Diona L Damian; John F Thompson; Richard A Scolyer; Kam-Meng Tchou-Wong; William R Levis
Journal:  J Drugs Dermatol       Date:  2010-11       Impact factor: 2.114

3.  Ingenol mebutate: potential for further development of cancer immunotherapy.

Authors:  Hung Q Doan; Nicholas Gulati; William R Levis
Journal:  J Drugs Dermatol       Date:  2012-10       Impact factor: 2.114

4.  SuperHapten: a comprehensive database for small immunogenic compounds.

Authors:  Stefan Günther; Dorothea Hempel; Mathias Dunkel; Kristian Rother; Robert Preissner
Journal:  Nucleic Acids Res       Date:  2006-11-07       Impact factor: 16.971

5.  A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.

Authors:  Lana Kandalaft; Ananda Mookerjee; Michele Graciotti
Journal:  Bioimpacts       Date:  2018-06-10

6.  Lithraea caustic (Litre) Extract Promotes an Antitumor Response Against B16 Melanoma.

Authors:  Claudia Robles-Planells; Sofia A Michelson; Javier Mena; Daniela Escrig; Juan L Rojas; Giselle Sanchez-Guerrero; Ronny Hernández; Carlos Barrera-Avalos; Leonel E Rojo; Daniela Sauma; Alexis M Kalergis; Mónica Imarai; Ricardo Fernández; Carolina A Robles; Elías Leiva-Salcedo; Rocio Santander; Alejandro Escobar; Claudio Acuña-Castillo
Journal:  Front Pharmacol       Date:  2019-10-22       Impact factor: 5.810

7.  Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata

Authors:  Zekayi Kutlubay; Ayşegül Sevim; Övgü Aydın; Suphi Vehid; Server Serdaroğlu
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.